187 related articles for article (PubMed ID: 19138651)
1. Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system.
Rapi S; Bazzini C; Tozzetti C; Sbolci V; Modesti PA
Transl Res; 2009 Feb; 153(2):71-6. PubMed ID: 19138651
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of two point-of-care analysers for lipid testing.
Shephard MD; Mazzachi BC; Shephard AK
Clin Lab; 2007; 53(9-12):561-6. PubMed ID: 18257461
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
[TBL] [Abstract][Full Text] [Related]
5. Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein.
Seamark DA; Backhouse SN; Powell R
Ann Clin Biochem; 2003 Mar; 40(Pt 2):178-80. PubMed ID: 12662408
[TBL] [Abstract][Full Text] [Related]
6. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities.
Shemesh T; Rowley KG; Shephard M; Piers LS; O'Dea K
Clin Chim Acta; 2006 May; 367(1-2):69-76. PubMed ID: 16388790
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
Rush E; Crook N; Simmons D
Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of analyses for lipid profile parameters as measured with the CR3000 system.
Sblendorio V; Palmieri B
Eur Rev Med Pharmacol Sci; 2008; 12(3):191-6. PubMed ID: 18700691
[TBL] [Abstract][Full Text] [Related]
9. Quality in point-of-care testing.
Nichols JH
Expert Rev Mol Diagn; 2003 Sep; 3(5):563-72. PubMed ID: 14510177
[TBL] [Abstract][Full Text] [Related]
10. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment.
Whitehead SJ; Ford C; Gama R
J Clin Pathol; 2014 Jun; 67(6):535-9. PubMed ID: 24711512
[TBL] [Abstract][Full Text] [Related]
11. Improving CardioCheck PA analytical performance: three-year study.
Matteucci E; Della Bartola L; Rossi L; Pellegrini G; Giampietro O
Clin Chem Lab Med; 2014 Sep; 52(9):1291-6. PubMed ID: 24695039
[TBL] [Abstract][Full Text] [Related]
12. Multicentre evaluation of a non-wipe system for the rapid determination of total cholesterol in capillary blood, Accutrend Cholesterol on Accutrend GC.
Gottschling HD; Reuter W; Ronquist G; Steinmetz A; Hattemer A
Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):373-81. PubMed ID: 7578618
[TBL] [Abstract][Full Text] [Related]
13. Assessing agreement between point of care and laboratory results for lipid testing from a clinical perspective.
Gialamas A; Laurence CO; Yelland LN; Tideman P; Worley P; Shephard MD; Tirimacco R; Willson KJ; Ryan P; Gill J; Thomas DW; Beilby JJ;
Clin Biochem; 2010 Mar; 43(4-5):515-8. PubMed ID: 19961841
[TBL] [Abstract][Full Text] [Related]
14. Matrix effects and the accuracy of cholesterol analysis.
Ross JW; Myers GL; Gilmore BF; Cooper GR; Naito HR; Eckfeldt J
Arch Pathol Lab Med; 1993 Apr; 117(4):393-400. PubMed ID: 8466403
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a glucose meter against analytical quality specifications for hospital use.
Singh Dhatt G; Agarwal M; Bishawi B
Clin Chim Acta; 2004 May; 343(1-2):217-21. PubMed ID: 15115699
[TBL] [Abstract][Full Text] [Related]
16. Challenges of implementing point-of-care testing (POCT) glucose meters in a pediatric acute care setting.
Kavsak PA; Zielinski N; Li D; McNamara PJ; Adeli K
Clin Biochem; 2004 Sep; 37(9):811-7. PubMed ID: 15329321
[TBL] [Abstract][Full Text] [Related]
17. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
18. Comparison of glucose point-of-care values with laboratory values in critically ill patients.
Shearer A; Boehmer M; Closs M; Dela Rosa R; Hamilton J; Horton K; McGrath R; Schulman C
Am J Crit Care; 2009 May; 18(3):224-30. PubMed ID: 19411582
[TBL] [Abstract][Full Text] [Related]
19. Experience with an external quality assessment programme for point-of-care-testing (POCT) devices for the determination of blood glucose.
Wood WG; Hanke R; Meissner D; Reinauer H
Clin Lab; 2003; 49(3-4):151-9. PubMed ID: 12705698
[TBL] [Abstract][Full Text] [Related]
20. ICSH Guideline for worldwide point-of-care testing in haematology with special reference to the complete blood count.
Briggs C; Carter J; Lee SH; Sandhaus L; Simon-Lopez R; Vives Corrons JL;
Int J Lab Hematol; 2008 Apr; 30(2):105-16. PubMed ID: 18333842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
